Center for Diabetes Research is an interdisciplinary research center that integrates clinical investigations with large-scale genetic analyses and different model systems. The center collaborates with various groups at the University of Bergen and Haukeland University Hospital in an effort to find new diabetes genes and map new mechanisms involved in diabetes development. The main aim is to develop new diagnostic tools that can be tested in population-based registries and biobanks before being used in clinical practice, thus facilitating individualized diabetes care.
The center has six principal investigators: (1) Professor Pål R. Njølstad, MD PhD; (2) Professor Helge Ræder, MD PhD; (3) Professor Simona Chera, PhD; (4) Professor Anders Molven, PhD; (5) Professor Stefan Johansson, PhD; Professor Valeriya Lyssenko, MD PhD.
The groups work together to:
1. Find new genetic risk factors for diabetes and its complications
2. Reveal novel disease mechanisms in diabetes development
3. Develop and implement improved targeted treatment of diabetes
We are located at the Children and Youth Hospital building, block 2, 6th floor, Haukelandsbakken 15, 5021 Bergen, Norway.
Publications from the Center for Diabetes Research can be found here.
We thank the Kristian Gerhard Jebsen Foundation (KGJ) for supporting important diabetes research in Bergen. We also thank the University of Bergen (UoB), Helse Vest, The Research Council of Norway (RCN), the Trond Mohn foundation (former BFS), Novo Nordisk Fonden and the European Research Council (ERC).
Most recent publications
- Extending protein interaction networks using proteoforms and small molecules
- Retention Time and Fragmentation Predictors Increase Confidence in Identification of Common Variant Peptides
- Global proteomics reveals insulin abundance as a marker of human islet homeostasis alterations
- Targeted Gene Silencing by Using GapmeRs in Differentiating Human-Induced Pluripotent Stem Cells (hiPSC) Toward Pancreatic Progenitors
- The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy